Fundraising FoxComera Life Sciences Holdings
Woburn, US · Founded 2022 · Delaware corporation
Find your way into Comera Life Sciences Holdings
Sign up to see every warm intro you have to Comera Life Sciences Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Comera Life Sciences Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MG
Michael Gerard CampbellExecutive
NM
Neal MuniExecutive
JM
Janice Marie McCourtExecutive
JS
Jeffrey S. HackmanExecutive
RP
Robert Patrick MahoneyNamed on SEC filing
SA
Stuart A. RandleNamed on SEC filing
SR
Sirshendu Roopom BanerjeeNamed on SEC filing
WA
William A. WexlerNamed on SEC filing
EA
Edward Aloysius Sullivan Jr.Named on SEC filing
KF
Kirsten FlowersNamed on SEC filing
Board
JS
James SherblomBoard director
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 4 rounds · 2023
▶$1.5MraisedJan 2024 · 12 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJan 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William A. WexlerDirector
- James SherblomDirector
- Dorothy J. ClarkeDirector
- Edward Aloysius Sullivan Jr.Director
- Sirshendu Roopom BanerjeeDirector
- Michael Gerard CampbellExecutive Officer
- Kirsten FlowersDirector
- Robert Patrick MahoneyExecutive Officer
- Jeffrey S. HackmanExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$238.3KraisedAug 2023 · 1 investors · BiotechnologyRule 506(b)
▶$238.3KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey S. HackmanExecutive Officer, Director
- Janice Marie McCourtExecutive Officer
- James SherblomDirector
- Michael Gerard CampbellExecutive Officer
- Sirshendu Roopom BanerjeeDirector
- Stuart A. RandleDirector
- Robert Patrick MahoneyExecutive Officer
- William A. WexlerDirector
- Edward Aloysius Sullivan Jr.Director
- Kirsten FlowersDirector
- Neal MuniExecutive Officer
- Offering amount
- $238.3K
- Amount sold
- $238.3K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.2MraisedAug 2023 · 12 investors · BiotechnologyRule 506(b)
▶$2.2MraisedAug 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert Patrick MahoneyExecutive Officer
- James SherblomDirector
- Stuart A. RandleDirector
- Sirshendu Roopom BanerjeeDirector
- Michael Gerard CampbellExecutive Officer
- William A. WexlerDirector
- Neal MuniExecutive Officer
- Edward Aloysius Sullivan Jr.Director
- Kirsten FlowersDirector
- Janice Marie McCourtExecutive Officer
- Jeffrey S. HackmanExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $2.2M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3.6MraisedJan 2023 · 14 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJan 2023 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Janice Marie McCourtExecutive Officer
- Jeffrey S. HackmanExecutive Officer, Director
- Michael Gerard CampbellExecutive Officer
- Sirshendu Roopom BanerjeeDirector
- Robert Patrick MahoneyExecutive Officer
- Stuart A. RandleDirector
- William A. WexlerDirector
- Edward Aloysius Sullivan Jr.Director
- Neal MuniExecutive Officer
- Kirsten FlowersDirector
- James SherblomDirector
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Comera Life Sciences Holdings raised?
- Comera Life Sciences Holdings has disclosed $7.5M raised across 4 rounds.
- Where is Comera Life Sciences Holdings headquartered?
- Comera Life Sciences Holdings is headquartered in Woburn, US.